Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / David Erritzoe
Person

David Erritzoe

Tracked across 1 events · 8 articles · First seen Feb 16, 2026 · Last active Feb 18, 2026

Sentiment
60
Attention
4
Events
1
Relationships
2
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
4 60
Tech
DMT Shows Rapid Antidepressant Effects in Trial
David Erritzoe, a neuroscientist at Imperial College London, was the lead investigator of the Dimethyltryptamine (DMT) trial. His work is central to the positive findings and the potential future development of DMT as a treatment.
Feb 16, 2026 · 8 articles
Relationships (2)
Tommaso Barba ↔ David Erritzoe Unknown
Cybin ↔ David Erritzoe Unknown
NEWSDESK
Track David Erritzoe live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.